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Background: The Japanese medical system is unique because it is the only country in the world where Western
medicine and traditional Japanese medicine including Kampo medicine, traditional Japanese herbal medicine, are
used in our daily clinical practice. Pain is essentially an interactive psychophysiological behavior pattern. Thus, an
interdisciplinary approach is often recommended in providing appropriate therapeutic care for the patients
suffering from chronic and intractable pain. In addition, we have been prescribing Kampo medicines in
combination with Western medicines as personalized medicine in order to treat patients with chronic pain at our
pain center. The aim of our study was to conduct a survey on the current use and the effect of Kampo medicines
in our multidisciplinary pain center.
Methods: Retrospective analysis was performed on 221 out of 487 patients suffering from chronic pain.
Results: The most frequent medical complaints for which Kampo medicines were prescribed were lower back/lower
limb pain, neck/upper limb pain, various facial pains, headache/migraine, whiplash-associated disorder, and frozen
shoulder. Kampo medicines were prescribed based on patient-centered Kampo diagnosis. Moreover, several Kampo
medicines generally for the management of psychological symptoms were prescribed for about 70% of the patients.
Pain improvement in the patients was categorized as follows: 26.3% with marked improvement, 12.7% with moderate
improvement, 38.9% with some improvement, and 19.9% with no improvement.
Conclusions: Two thirds of the chronic pain patients with the use of Kampo medicines combined with Western
medicine experienced further pain improvements.
Keywords: Kampo medicine, Multidisciplinary pain center, Chronic and intractable painOverview
Traditional, complementary, and alternative therapies
are widely used and researched in the USA and Europe
[1,2]. One of the underlying reasons for this is to reduce
the high costs of health care. There is a national health
insurance system which enables everyone in Japan to re-
ceive advanced health care at a low cost. Another char-
acteristic of the health insurance system in Japan is that
patients can access Western and Kampo medical care at* Correspondence: arainon@aichi-med-u.ac.jp
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Nagakutecho, Aichigun, Aichi 480-1195, Japan
© 2014 Arai et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.the same time in the same medical institution [1,2]. Kampo,
or traditional Japanese herbal medicine based on traditional
Chinese herbal medicine, has been used for the treatment
of not only acute but also chronic pain in Japan [3]. The
Ministry of Health, Labor and Welfare of Japan, approves
the use of 148 Kampo preparations (traditional herbal
medicines) [4]. Currently, most Kampo preparations are
prescribed as extract formulations of high quality. More-
over, physicians who have studied Western medicine and
Kampo medicine practice Western and Kampo medical
care in their daily clinical practice.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Patient's characteristics
Patient's characteristics Values
Age (years) 57 [13–89]
Sex (M/F) 79/142
Weight (kg) 56 [34–92]
Duration of pain (months) 58 [3–400]
Values are numbers or mean [range].
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http://www.epmajournal.com/content/5/1/10Pain is essentially an interactive psychophysiological be-
havior pattern, so an appreciation of the biopsychosocial
model is essential for understanding and caring for patients
with chronic pain. Thus, an interdisciplinary approach is
often recommended and considered to be extremely rele-
vant in providing appropriate therapeutic care for patients
suffering from chronic and intractable pain [5]. Our center
is the first multidisciplinary pain center established in Japan
at July 2007. At our center, we have been prescribing
Kampo extract formulations in combination with Western
medicines in our daily clinical practice as an interdisciplin-
ary approach in order to treat patients with chronic pain.
However, to date, there have not been any reports on
Kampo practice in multidisciplinary pain centers any-
where in the world because of the health insurance
systems. We thus conducted a survey on the use of
Kampo extract formulations and the effect of the
formulations on patients with chronic pain in our multi-
disciplinary pain center.
Methods
Retrospective analysis from August 2012 to July 2013 was
performed on 487 patients suffering from chronic pain
who visited the pain center of Aichi Medical University
Hospital. All patients were referred from other hospitals
to the pain center. Patients who were prescribed Kampo
extract formulations were included.
After obtaining approval from the Ethics Committee of
Aichi Medical University (a reference number, 13–097)
and written informed consent, we routinely recorded
demographics, symptoms, and course of pain in all pa-
tients. The intensity of pain was rated by the patients
using a numerical rating scale (NRS) where 0 indicated
no pain and 10 the greatest pain possible. All demo-
graphic and clinical data were extracted from medical
records from August 2012 to March 2014 for the
present study. In addition, patients were categorized as
having marked improvement (≥60% improvement in
NRS for pain compared to initial visit), moderate improve-
ment (≥30% and <60% improvement in NRS compared
to initial visit), some improvement (≥20% and <30%
improvement in NRS compared to initial visit), and no
improvement (<20% improvement in NRS compared to
initial visit) depending on the state of pain improve-
ment 6 months to 1 year after the initial visit. More-
over, patients who did not visit the hospital again even
with an appointment for a follow-up visit and who vis-
ited the hospital for the purpose of receiving a second
opinion were categorized separately.
Results
We administered treatment after a medical conference
attended by different types of professionals (anesthesiolo-
gists, orthopedists, psychiatrists, internists, dentists, nurses,physical therapists, and clinical psychotherapists). As
required at the medical conference, we administered
pharmacological (including Kampo medicine), physical,
acupuncture, cognitive-behavioral, psychoanalytic, and
psychological treatment. Kampo medicines were pre-
scribed for 221 patients out of a total of 487 patients
based on patient-centered Kampo diagnosis [3] while
continuing Western medical care and the demographic
characteristic data are presented in Table 1. Table 2 lists
the most frequent medical complaints for which Kampo
medicines were prescribed. Kampo medicines were pre-
scribed to treat lower back/lower limb pain (36.6%, n = 81),
neck/upper limb pain (13.1%, n = 29), various facial pains
(13.1%, n = 29), headache/migraine (7.7%, n = 17),
whiplash-associated disorder (5.9%, n = 13), and frozen
shoulder (3.6%, n = 8). Pain improvement in all the pa-
tients who were prescribed Kampo medicines was cate-
gorized as follows: 26.3% with marked improvement,
12.7% with moderate improvement, 38.9% with some
improvement, and 19.9% with no improvement. Table 3
shows Kampo therapy outcome of each complaint.
Table 4 lists the most frequently prescribed Kampo
medicines for lower back/lower limb pain. We pre-
scribed Goshajinkigan (22.2%, n = 18), Shakuyakukanzoto
(17.3%, n = 14), Yokukansan (16.0%, n = 13), Keishikajut-
subuto (14.8%, n = 12), Hachimijiogan (14.8%, n = 12),
and Juzentaihoto (14.8%, n = 12) for the management of
lower back/lower limb pain. Pain improvement in the
patients who were prescribed Kampo medicines was cat-
egorized as follows (Table 3): 23.5% with marked im-
provement, 17.3% with moderate improvement, 23.5%
with some improvement, and 28.4% with no improve-
ment. In contrast, pain improvement in the patients who
were not prescribed Kampo medicines (n = 136; median
(range) of pain duration, 24 (3–320) months) was cate-
gorized as follows: 19.1% (n = 26) with marked improve-
ment, 6.9% (n = 9) with moderate improvement, 12.5%
(n = 17) with some improvement, and 25.0% (n = 34)
with no improvement.
Table 4 lists the most frequently prescribed Kampo
medicines for neck/upper limb pain. We prescribed
Keishibukuryogan (34.5%, n = 10), Yokukansan (24.1%,
n = 7), Jidabokuippo (17.3%, n = 5), Tokishakuyakusa
(17.3%, n = 5), Kamishoyosan (13.8%, n = 4), Kakkonto
(13.8%, n = 4), and Kososan (13.8%, n = 4) for the
Table 2 Most frequent medical complaints for which
Kampo medicines were prescribed
Medical complaint % (n)
Lower back/lower limb pain 36.6 (81)
Neck/upper limb pain 13.1 (29)
Various facial pains 13.1 (29)
Headache/migraine 7.7 (17)
Whiplash-associated disorder 5.9 (13)
Frozen shoulder 3.6 (8)
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http://www.epmajournal.com/content/5/1/10management of neck/upper limb pain. Pain improve-
ment in the patients who were prescribed Kampo medi-
cines was categorized as follows (Table 3): 34.5% with
marked improvement, 20.6% with moderate improve-
ment, 13.7% with some improvement, and 17.2% with
no improvement. In contrast, pain improvement in the
patients who were not prescribed Kampo medicines
(n = 65; median (range) of pain duration, 24 (3–168)
months) was categorized as follows (Table 3): 20.0%
(n = 13) with marked improvement, 9.2% (n = 6) with
moderate improvement, 13.8% (n = 9) with some improve-
ment, and 26.2% (n = 17) with no improvement.
Table 4 lists the most frequently prescribed Kampo
medicines for various facial pains. We prescribed
Kamishoyosan (44.8%, n = 13), Yokukansan (44.8%, n =
13), Maobushisaishinto (20.7%, n = 6), Keishibukuryogan
(10.3%, n = 3), and Goreisan (10.3%, n = 3) for the man-
agement of various facial pains. Pain improvement in
the patients was categorized as follows (Table 3): 34.5%
with marked improvement, 17.2% with moderate im-
provement, 10.3% with some improvement, and 30.8%
with no improvement.
Table 4 lists the most frequently prescribed Kampo
medicines for headache/migraine. We prescribed Keishi-
bukuryogan (29.4%, n = 5), Kamishoyosan (23.5%, n = 4),
Goshuyuto (23.5%, n = 4), and Jidabokuippo (23.5%, n = 4)
for the management of headache/migraine. Pain im-
provement in the patients who were prescribed Kampo
medicines was categorized as follows (Table 3): 47.0%Table 3 Duration of pain and Kampo therapy outcome
LB/LL pain N/UL pain Various facial pa
Duration of pain (months)
Median (range) 30 (3–360) 24 (3–360 ) 24 (3–360)
Improvement % (n) % (n) % (n)
Marked 23.5 (19) 34.5 (10) 34.5 (10)
Moderate 17.3 (14) 20.6 (6) 17.2 (5)
Some 23.5 (19) 13.7 (61) 10.3 (3)
No 28.4 (23) 17.2 (5) 30.8 (9)
Dropouts 4.8 (4) 10.3(3) 6.9 (2)
Of 221 new patients at Aichi Medical University Multidisciplinary Pain Center. LB/LL
disorder, whiplash-associated disorder.with marked improvement, 12.8% with some improve-
ment, and 17.6% with no improvement. In contrast, pain
improvement in the patients who were not prescribed
Kampo medicines (n = 20; median (range) of pain dur-
ation, 42 (3–240) months) was categorized as follows:
25.0% (n = 5) with marked improvement, 10.0% (n = 2)
with moderate improvement, 10.0% (n = 2) with some
improvement, and 15.0% (n = 3) with no improvement.
Table 4 lists the most frequently prescribed Kampo
medicines for whiplash-associated disorder. We pre-
scribed Jidabokuippo (61.5%, n = 8), Keishibukuryogan
(38.5%, n = 5), Tokishakuyakusa (23.1%, n = 3), Mao-
bushisaishinto (15.4%, n = 2), and Yokukansan (15.4%, n
= 2) for the management of whiplash-associated dis-
order. Pain improvement in the patients who were pre-
scribed Kampo medicines was categorized as follows
(Table 3): 30.8% with marked improvement, 15.4% with
moderate improvement, 7.9% with some improvement,
and 30.8% with no improvement. In contrast, pain im-
provement in the patients who were not prescribed
Kampo medicines (n = 12; median (range) of pain dur-
ation, 18 (3–144) months) was categorized as follows:
8.3% (n = 1) with marked improvement, 16.7% (n = 2)
with some improvement, and 33.5% (n = 17) with no
improvement.
Table 4 lists the most frequently prescribed Kampo
medicines for frozen shoulder. We prescribed Nijutsuto
(87.5%, n = 7) and Keishikajutsubuto (37.5%, n = 3) for
the management of frozen shoulder. Pain improvement
in the patients was categorized as follows (Table 3):
88.9% with marked improvement and 11.1% with moder-
ate improvement.
Expert recommendations
Since the 1970s, great attention has been given to trad-
itional, complementary, and alternative therapies around
the world [1,2]. One of the reasons for the attention is
the limited effectiveness of biomedicine for the treatment
of chronic diseases. Based on the Japanese health insu-
rance system, we can use Western medicine and traditionalins Headache/migraine W-A disorder Frozen shoulder
36 (3–360) 12 (3–360) 18 (3–36)
% (n) % (n) % (n)
47.0 (8) 30.8 (4) 88.9 (7)
0.0(0) 15.4 (2) 11.1 (1)
12.8 (2) 7.9 (1) 0.0 (0)
17.6 (3) 30.8 (4) 0.0 (0)
23.5 (4) 15.4 (2) 0.0 (0)
pain, lower back/lower limb pain; N/UL pain, neck/upper limb pain; W-A
Table 4 Most frequently prescribed Kampo medicines
Kampo medicine % (n) Ingredients (6, 8)
Lower back/Lower limb pain
Goshajinkigan 22.2 (18) Rehmannia, Cornus, Dioscorea, Alisma, Hoelen, Moutan, Cinnamon, Aconite, Achyranthes, Plantago Jukujio
Shakuyakukanzoto 17.3 (14) Glycyrrhizae radix, Peony, Liquorice
Yokukansan 16.0 (13) Tang-kuei, Gambir, Cnidium, Atractylodes, Holen, Bupleurum, Liquorice
Keishikajutsubuto 14.8 (12) Cinnamon, Hoelen, Moutan, Persica, Peony
Hachimijiogan 14.8 (12) Rehmannia, Cornus, Dioscorea, Alisma, Hoelen, Moutan, Cinnamon, Aconite
Juzentaihoto 14.8 (12) Ginseng, Astragalus, White atractylodes, Tang-kuei, Hoelen, Rehmannia, Cnidium, Peony, Cinnamon, Liquorice
Neck/Upper limb pain
Keishibukuryogan 34.5 (10) Cinnamon, Atractylodes, Aconite
Yokukansan 24.1 (7) Tang-kuei, Gambir, Cnidium, Atractylodes, Holen, Bupleurum, Liquorice
Jidabokuippo 17.3 (5) Cinnamon, Cnidium, Glycyrrhizae radix, Rhei rhizome, Quercus, Caryophylli, Nupharis rhizoma
Tokishakuyakusa 17.3 (5) Tang-kuei, Cnidium, Peony, Hoelen, Atractylodes, Alisma
Kamishoyosan 13.8 (4) Tang-kuei, Peony, Atractylodes, Hoelen, Bupleurum, Liquorice, Moutan, Gardenia, Ginger, Mentha
Kakkonto 13.8 (4) Pueraria, Ma-huang, Ginger, Jujube, Cinnamon, Peony, Liquorice
Kososan 13.8 (4) Cyperus, Perilla, Citrus, Ginger, Liquorice
Various facial pains
Kamishoyosan 44.8 (13) Tang-kuei, Peony, Atractylodes, Hoelen, Bupleurum, Liquorice, Moutan, Gardenia, Ginger, Mentha
Yokukansan 44.8 (13) Tang-kuei, Gambir, Cnidium, Atractylodes, Holen, Bupleurum, Liquorice
Maobushisaishinto 20.7 (6) Ma-huang, Asarum, Aconite
Keishibukuryogan 10.3 (3) Cinnamon, Atractylodes, Aconite
Goreisan 10.3 (3) Alisma, Polyporus, Hoelen, Atractylodes, Cinnamon
Headache/Migraine
Keishibukuryogan 29.4 (5) Cinnamon, Atractylodes, Aconite
Kamishoyosan 23.5 (4) Tang-kuei, Peony, Atractylodes, Hoelen, Bupleurum, Liquorice, Moutan, Gardenia, Ginger, Mentha
Goshuyuto 23.5 (4) Evodia, Ginseng, Ginger, Jujube
Jidabokuippo 23.5 (4) Cinnamon, Cnidium, Glycyrrhizae radix, Rhei rhizome, Quercus cortex, Caryophylli, Nupharis Rhizoma
Whiplash-associated disorder
Jidabokuippo 61.5 (8) Cinnamon, Cnidium, Glycyrrhizae radix, Rhei rhizome, Quercus cortex, Caryophylli, Nupharis Rhizoma
Keishibukuryogan 38.5 (5) Cinnamon, Atractylodes, Aconite
Tokishakuyakusan 23.1 (3) Tang-kuei, Cnidium, Peony, Hoelen, Atractylodes, Alisma
Maobushisaishinto 15.4 (2) Ma-huang, Asarum, Aconite
Yokukansan 15.4 (2) Tang-kuei, Gambir, Cnidium, Atractylodes, Holen, Bupleurum, Liquorice
Frozen shoulder
Nijutsuto 87.5 (7) White and blue atractylodes, Hoelen, Citrus, Arisaema, Cyperus, Scute, Clematis, Chianghuo, Pinellia, Liquorice, Ginger
Keishikajutsubuto 37.5 (3) Cinnamon, Hoelen, Moutan, Persica, Peony
For lower back/lower limb pain, neck/upper limb pain, various facial pains, headache/migraine, whiplash-associated disorder, and frozen shoulder.
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http://www.epmajournal.com/content/5/1/10Japanese medicine including Kampo medicine in our daily
clinical practice at the same time in the same medical insti-
tution [1,2,4]. Furthermore, Kampo has been used for the
treatment of chronic pain in Japan from ancient times to
the present [3,6,7].
The results of the present survey showed that Kampo
medicines were prescribed to treat lower back/lower
limb pain (36.6%, n = 81), neck/upper limb pain (13.1%,
n = 29), various facial pains (13.1%, n = 29), headache/migraine (7.7%, n = 17), whiplash-associated disorder
(5.9%, n = 13), and frozen shoulder (3.6%, n = 8). In fact,
we had these cases in the same order in our center and
Kampo medicines were prescribed when treatment with
Western medicine alone was insufficient. And this sur-
vey shows that the use of Kampo medicines combined
with Western medicine as an interdisciplinary approach
provided some improvements for two thirds of these pa-
tients refractory to Western medicine alone.
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kajutsubuto, Hachimijiogan, and Juzentaihoto were the
most frequently prescribed Kampo medicines for lower
back/lower limb pain. Goshajinkigan, Shakuyakukanzoto,
Keishikajutsubuto, and Hachimijiogan have been used
since ancient times to treat melosalgia, low back pain, and
numbness [8-11]. Yokukansan has been used to treat
excitability, depression, and excessive muscle tension
[8,9,12].
Keishibukuryogan, Yokukansan, Jidabokuippo, Tokisha-
kuyakusa, Kamishoyosan, Kakkonto, and Kososan were
the most frequently prescribed Kampo medicines for
neck/upper limb pain. Keishibukuryogan, Yokukansan,
Tokishakuyakusa, Kamishoyosan, Kakkonto, and Kososan
have been used for the management of headache and
chronic neck pain [8,9,13,14].
Kamishoyosan, Yokukansan, Maobushisaishinto, Keishi-
bukuryogan, and Goreisan were the most frequently
prescribed Kampo medicines for various facial pains.
Keishibukuryogan, Kamishoyosan and Yokukansan have
been prescribed to manage emotional distress, head-
ache, and clenching or grinding of the teeth [8,9,12-14].
Keishibukuryogan, Kamishoyosan, Goshuyuto, and Jida-
bokuippo were the most frequently prescribed Kampo
medicines for headache/migraine. Goshuyuto has been
used since ancient times to treat a very severe headache
accompanied by vomiting [8,9,15]. Moreover, Keishibu-
kuryogan and Kamishoyosan have been prescribed for the
treatment of emotional distress, a heavy feeling in the
head and headache [8,9,13,14].
Jidabokuippo, Keishibukuryogan, Tokishakuyakusa, Mao-
bushisaishinto, and Yokukansan were the most frequently
prescribed Kampo medicines for whiplash-associated
disorder. Jidabokuippo and Keishibukuryogan have been
prescribed for the management of sprains and trauma or
bruises [6,8,9,14].
Nijutsuto and Keishikajutsubuto were the most fre-
quently prescribed Kampo medicines for frozen shoulder.
Nijutsuto has been the first-line Kampo medicine for the
treatment of frozen shoulder [8,9]. Keishikajutsubuto has
been used to treat arthritis [9].
The interesting thing about the present survey is that we
usually prescribed Yokukansan, Kamishoyosan, and
Kososan, which have generally been prescribed for the
management of psychological symptoms [3,12,13,16,17].
Yokukansan and Kamishoyosan have anxiolytic effects
[12,13,17] and especially Yokukansan which is known to
exert these effects via serotonin receptors [12]. Pain is es-
sentially an interactive psychophysiological behavioral pat-
tern [5]. Our previous study also showed that about 70% of
patients were moderate to high psychopathological patients
[3]. We thus postulated that Yokukansan, Kamishoyosan,
and Kososan were used for psychopathological patients suf-
fering from chronic pain at our center.Since pain is an interactive psychophysiological behav-
ioral pattern, it is important for medical staffs to recognize
the biopsychosocial model when understanding and car-
ing for patients with chronic pain. Thus, an interdisciplin-
ary approach is often recommended and considered to be
extremely relevant in providing appropriate therapeutic
care for patients with chronic and intractable pain [5].
That is, inter-, multidisciplinary integrated approach is
needed for patients with chronic and intractable pain as
personalized medicine. Kampo has been used for the
treatment of chronic pain in Japan from ancient times to
the present [3,6,7]. Also, Kampo medicines have been pre-
scribed based on patient-centered Kampo diagnosis. Thus,
we postulate that Kampo could be part of personalized
medicine. Accordingly, we have been prescribing Kampo
extract formulations in combination with Western medi-
cines in our daily clinical practice as personalized medi-
cine in order to treat patients with chronic pain at our
center. And we expect that the number of physicians who
use Kampo in this way will increase soon.
There are merits and demerits for the clinical applica-
tion of Kampo medicine, when compared with Western
medicine. A lot of patients value Kampo medicine as a
holistic, body harmonizing treatment and as a stimulant
for self-healing without severe side effects [1]. In con-
trast, some patients suffering from chronic pain are
likely to be so dependent and tend to be reluctant to re-
ceive the treatments based on its holistic, self-healing
philosophy.
There are several limitations of the study. The present re-
port is a retrospective and nonrandomized control analysis
of Kampo treatment and thus lacks the reproducibility.
Since we have to clarify the specific kind of pain for person-
alized approach and detailed points for multidisciplinary in-
tegration, we need prospective and comparative study that
might be more appropriate to support predictive, prevent-
ive, personalized value, and the reproducibility of Kampo
treatment, thereby obtaining solid evidence of Kampo
medicine in personalized pain management algorithm.
Conclusion
The retrospective analysis on 221 out of 487 patients
suffering from chronic pain who visited the pain center
of Aichi Medical University Hospital showed that the
most frequent medical complaints for which Kampo
medicines were prescribed were lower back/lower limb
pain, neck/upper limb pain, various facial pains, head-
ache/migraine, whiplash-associated disorder, and frozen
shoulder. Two thirds of the chronic pain patients with
the use of Kampo medicines combined with Western
medicine experienced further pain improvements. More-
over, we usually used several Kampo medicines gener-
ally prescribed for the management of psychological
symptoms.
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